期刊
ACS CATALYSIS
卷 10, 期 15, 页码 8880-8897出版社
AMER CHEMICAL SOC
DOI: 10.1021/acscatal.0c02377
关键词
tertiary amide; lactam; reductive functionalization; iridium catalysis; hydrosilylation; amine
资金
- EPSRC Centre for Doctoral Training in Synthesis for Biology and Medicine [EP/L015838/1]
- AstraZeneca
- Diamond Light Source
- Defence Science and Technology Laboratory
- Evotec
- GlaxoSmithKline
- Janssen
- Novartis
- Pfizer
- Syngenta
- Takeda
- UCB
- Vertex
- Leverhulme Trust [RPG-2017-069]
- King Abdulaziz University (KAU)
- Honjo International Scholarship Foundation
The tertiary amide is a ubiquitous functional group and plays an irreplaceable role in medicinal chemistry. Its robust nature has meant-in the past-that selective manipulation of this motif remained elusive. The reductive activation through hydrosilylation of tertiary amides-using Vaska's complex (IrCl(CO)-(PPh3)(2))-has emerged as a powerful strategy for the chemo-selective transformation of amides into reactive enamines and iminium ions. Furthermore, these synthetically valuable species can be accessed in the presence of traditionally more reactive functional groups. This approach to amide reductive activation via hydro- silylation has been exploited in a range of downstream C-C bond forming processes and has seen significant applications in total synthesis, enabling streamlined routes for the synthesis of complex natural product architectures. This perspective covers the development of this synthetic strategy, from initial hydrosilylation studies to its flourishing use in the reductive functionalization of amide-containing molecules, both simple and complex.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据